Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
The purpose of this study is to meet a PMA condition of approval of the BHR System. The study will evaluate the long term safety and effectiveness of the BHR system in patients with non-inflammatory and inflammatory arthritis.
• At least 21 years of age and skeletally mature
• Patients requiring primary hip resurfacing due to:
• Non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis, traumatic arthritis, avascular necrosis, or dysplasia/DDH
• Inflammatory arthritis such as rheumatoid arthritis
• Subject or his/her legal guardian is willing to consent to participate in the study by signing and dating the approved consent form
• Subject is available for clinical follow-up through at least ten years
• Subject meets none of the exclusion criteria